Join Growin Stock Community!
Beta
Back to CVS.US Analysis

Ticker

Value

empty

There is no following symbol in this watchlist.

  • Operating ROA
  • ROS
  • Profit Margin
ros-chart

CVS ROS

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

The latest data point for CVS's Return on Sales (ROS) in Q4'25 stands at 2.04%, reflecting a modest recovery from the negative territory observed in the prior quarter. This value indicates improved profitability margins for the period ending December 31, 2025, though it remains below the highs seen earlier in the fiscal year. Over the timeframe from Q2'23 to Q4'25, CVS's ROS has exhibited a volatile downward trend overall, starting at 3.65% and peaking at 4.13% in Q3'23 before steadily declining to a low of -2.61% in Q3'25, with intermittent recoveries such as 3.59% in Q1'25. Key inflection points include a sharp drop in Q3'24 to 0.91% and the unprecedented negative reading in Q3'25, signaling potential operational challenges or cost pressures, while the area chart highlights periods of instability rather than sustained growth. No data is available for Q1'26, limiting forward visibility.